Related references
Note: Only part of the references are listed.Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan
Fu-Chih Hsiao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Assessment of resistance vessel function in human skeletal muscle: guidelines for experimental design, Doppler ultrasound, and pharmacology
Jacqueline K. Limberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
Maria Vincenza Polito et al.
SCIENTIFIC REPORTS (2020)
Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction
Kanokwan Bunsawat et al.
EXPERIMENTAL PHYSIOLOGY (2020)
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Anis Hanna et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Sacubitril/valsartan can improve exercise performance in systolic chronic heart failure patients: a case report
Massimo Mapelli et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol
Yi Zeng et al.
BMC CANCER (2019)
Strong Relationship Between Vascular Function in the Coronary and Brachial Arteries A Clinical Coming of Age for the Updated Flow-Mediated Dilation Test?
Ryan M. Broxterman et al.
HYPERTENSION (2019)
Exercise Intolerance in Patients With Heart Failure
Marco Giuseppe Del Buono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Shannon M. Dunlay et al.
CIRCULATION (2019)
Feature article: LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis
Qing Ge et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Practical guidance on the use of sacubitril/valsartan for heart failure
Andrew J. Sauer et al.
HEART FAILURE REVIEWS (2019)
Change in renal function associated with drug treatment in heart failure: national guidance
Andrew L. Clark et al.
HEART (2019)
6-minute walking test: a useful tool in the management of heart failure patients
Sophia Giannitsi et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2019)
Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension
Stefan Engeli et al.
HYPERTENSION (2018)
Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study
Paola Beltran et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
Rishi K. Trivedi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half
Melissa A. Lyle et al.
MAYO CLINIC PROCEEDINGS (2018)
Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease
Katherine G. Garlo et al.
JAMA NETWORK OPEN (2018)
Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction
D. Walter Wray et al.
HEART FAILURE REVIEWS (2017)
Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review
Richard W. Bohannon et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Reactive hyperemia is associated with adverse clinical outcomes in heart failure
Nicola J. Paine et al.
AMERICAN HEART JOURNAL (2016)
Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
Zhanna Kobalava et al.
CARDIOVASCULAR THERAPEUTICS (2016)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
Barbara S. Wiggins et al.
CIRCULATION (2016)
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Pardeep S. Jhund et al.
HEART (2016)
Assessing the perceived quality of brachial artery Flow Mediated Dilation studies for inclusion in meta-analyses and systematic reviews: Description of data employed in the development of a scoring ;tool based on currently accepted guidelines
Arno Greyling et al.
DATA IN BRIEF (2016)
Innate Immunity and the Failing Heart The Cytokine Hypothesis Revisited
Douglas L. Mann
CIRCULATION RESEARCH (2015)
Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review
Jonathan Yap et al.
CLINICAL CARDIOLOGY (2015)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
Effect of 6-Month Therapy With Perindopril A on Structural-Functional State of Arterial Vascular Bed in Patients With Chronic Heart Failure
Yu.N. Belenkov Belenkov et al.
KARDIOLOGIYA (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Is Flow-Mediated Dilation Nitric Oxide Mediated? A Meta-Analysis
Daniel J. Green et al.
HYPERTENSION (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Reactive Hyperemia Occurs Via Activation of Inwardly Rectifying Potassium Channels and Na+/K+-ATPase in Humans
Anne R. Crecelius et al.
CIRCULATION RESEARCH (2013)
Serum Interleukin-18 Levels Are Associated with Physical Activity in Japanese Men
Kanae Oda et al.
PLOS ONE (2013)
Vascular Function and the Role of Oxidative Stress in Heart Failure, Heart Transplant, and Beyond
Melissa A. H. Witman et al.
HYPERTENSION (2012)
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline
Dick H. J. Thijssen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Interleukin 18 and coronary heart disease: Prospective study and systematic review
Barbara J. M. H. Jefferis et al.
ATHEROSCLEROSIS (2011)
Microvascular Function Predicts Cardiovascular Events in Primary Prevention Long-Term Results From the Firefighters and Their Endothelium (FATE) Study
Todd J. Anderson et al.
CIRCULATION (2011)
Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase
Shunichi Takiguchi et al.
HYPERTENSION RESEARCH (2011)
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling - Results from a randomized, double-blind, and placebo-controlled study
Sandra Erbs et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Ultrasound Assessment of Flow-Mediated Dilation
Ryan A. Harris et al.
HYPERTENSION (2010)
Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan
Takehiko Wago et al.
HYPERTENSION RESEARCH (2010)
Six-Minute Walk Test and Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure A Comparative Analysis on Clinical and Prognostic Insights
Marco Guazzi et al.
CIRCULATION-HEART FAILURE (2009)
Tumor necrosis factor-α and mortality in heart failure -: A community study
Shannon M. Dunlay et al.
CIRCULATION (2008)
Valsartan therapy in heart failure after myocardial infarction: The role of endothelial dependent vasorelaxation
Hoang Thai et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Long-term use of sildenafil in the therapeutic management of heart failure
Marco Guazzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery
Alex L. Huang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Limb-specific differences in flow-mediated dilation: the role of shear rate
Steven K. Nishiyama et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients - A randomized study
Ulrik Wisloff et al.
CIRCULATION (2007)
Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function
G Poelzl et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Relationship between exercise intolerance and levels of neurohormonal factors and proinflammatory cytokines in patients with stable chronic heart failure
K Itoh et al.
INTERNATIONAL HEART JOURNAL (2005)
Relationship between endothelial function in the coronary and brachial arteries
H Teragawa et al.
CLINICAL CARDIOLOGY (2005)
Flow-mediated vasodilation predicts outcome in patients with chronic heart failure -: Comparison with B-type natriuretic peptide
B Meyer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure
L Ingle et al.
EUROPEAN HEART JOURNAL (2005)
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
SD Katz et al.
CIRCULATION (2005)
Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death
D Fischer et al.
EUROPEAN HEART JOURNAL (2005)
Endothelial dysfunction in congestive heart failure:: ACE inhibition vs. angiotensin II antagonism
A Schäfer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure
M Nakamura et al.
JOURNAL OF CARDIAC FAILURE (2004)
Immediate exercise hyperemia: contributions of the muscle pump vs. rapid vasodilation
ME Tschakovsky et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
The 6-minute walk test: How important is the learning effect?
G Wu et al.
AMERICAN HEART JOURNAL (2003)
Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats
MD Costa et al.
HYPERTENSION (2000)
Share Paper
